InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
T+90 hit rate
80%
T+90 mean return
+7.7%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Reitan Colleen F, Director. Director active across 2 companies, notably Myriad Genetics INC. In total, 9 reports have been published. Split: 1 buy · 1 sell. Total volume traded: €1.2m. History available since 3 June 2021. The latest transaction was disclosed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
671 shares0Common StockSEC:0001178670-26-000040:0
18,000 shares@ US$100.65Common StockSEC:0001735276-25-000097:0
49,796 shares0Common StockSEC:0001628280-25-029973:0
32 shares@ US$286.00100.0% of flowCommon StockSEC:0001735276-25-000062:0
Canonical exit: 27 Nov 2024 (T+90)
46,012 shares@ US$27.946100.0% of flowCommon StockSEC:0001628280-24-039405:0
15,695 shares0Common StockSEC:0001628280-24-027331:0
15,151 shares0Common StockSEC:0001628280-23-020711:0
17,275 shares0Common StockSEC:0001628280-22-016217:0
12,848 shares0Common StockSEC:0000899243-21-022153:0
9 of 9 declarations
About Reitan Colleen F
Colleen F. Reitan is a Board Member at Myriad Genetics Inc. She plays a vital role in overseeing the company's activities and developing strategies aimed at fostering innovation and growth. Her experience in the healthcare sector is beneficial for the organization.
